J8700
J8700 – Temozolomide, oral, 5 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 35 NDCs crosswalked per 5 MG $0.425/unit ASP+6%
📋 J8700 summary
J8700 is a HCPCS Level II J-code used to bill Temozolomide, oral, 5 mg, billed per 5 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Code J8700
Billing unit 5 MG Payment limit $0.425/unit NDC-Crosswalk 35
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ8700
DescriptorTemozolomide, oral, 5 mg
Billing unit5 MG
Payment limit / unit$0.425
Est. ASP / unit$0.401 est.
Mapped NDCs35
Data periodQ3 2026
Last updated2026-08-20
💊 About Temozolomide DRUG GUIDE
Temozolomide treats two types of aggressive brain tumors in adults: glioblastoma and anaplastic astrocytoma.
For newly diagnosed glioblastoma, it is given alongside radiation therapy and then continued as maintenance treatment.For anaplastic astrocytoma, Temodar (the brand-name injection/capsule product) is approved for adjuvant treatment of newly diagnosed cases as well as refractory cases (tumors that have stopped responding to other treatment).
Temozolomide Capsules, USP are approved for newly diagnosed glioblastoma and for refractory anaplastic astrocytoma in patients whose disease progressed on a regimen containing nitrosourea and procarbazine.
Clinical overview from our editorial drug guide for Temozolomide. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.425
Est. ASP / unit
$0.401 est.
Est. after 2% sequester
$0.417
HCPCS dosage
5 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionTemozolomide, oral, 5 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment group—
Action codeN — No maintenance this year
Effective date2018-01-01
Date added2001-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J8700 = 5 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J8700 LEAST EXPENSIVE FIRST
35 NDCs map to J8700. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.425/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 16729-0049-53 | Temozolomide 20 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-049-53)... | 20 mg/1 | 20 | $8.50 | $0.880 | ● Active | CMS ASP |
| 16729-0049-54 | Temozolomide 20 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-049-54)... | 20 mg/1 | 56 | $23.80 | $0.880 | ● Active | CMS ASP |
| 47335-0891-72 | Temozolomide 20 mg/1 CAPSULE | Sun | 15 BLISTER PACK in 1 CARTON (47335-891-72)... | 20 mg/1 | 60 | $25.50 | $0.880 | ● Active | CMS ASP |
| 47335-0891-74 | Temozolomide 20 mg/1 CAPSULE | Sun | 5 BLISTER PACK in 1 CARTON (47335-891-74)... | 20 mg/1 | 20 | $8.50 | $0.880 | ● Active | CMS ASP |
| 65162-0802-14 | Temozolomide 20 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-802-14) / 14... | 20 mg/1 | 56 | $23.80 | $0.880 | ● Active | CMS ASP |
| 65162-0802-51 | Temozolomide 20 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-802-51) / 5 C... | 20 mg/1 | 20 | $8.50 | $0.880 | ● Active | CMS ASP |
| 16729-0048-53 | Temozolomide 5 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-048-53)... | 5 mg/1 | 5 | $2.13 | $1.931 | ● Active | CMS ASP |
| 16729-0048-54 | Temozolomide 5 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-048-54)... | 5 mg/1 | 14 | $5.95 | $1.931 | ● Active | CMS ASP |
| 47335-0890-72 | Temozolomide 5 mg/1 CAPSULE | Sun | 15 BLISTER PACK in 1 CARTON (47335-890-72)... | 5 mg/1 | 15 | $6.38 | $1.931 | ● Active | CMS ASP |
| 47335-0890-74 | Temozolomide 5 mg/1 CAPSULE | Sun | 5 BLISTER PACK in 1 CARTON (47335-890-74)... | 5 mg/1 | 5 | $2.13 | $1.931 | ● Active | CMS ASP |
| 65162-0801-14 | Temozolomide 5 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-801-14) / 14... | 5 mg/1 | 14 | $5.95 | $1.931 | ● Active | CMS ASP |
| 65162-0801-51 | Temozolomide 5 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-801-51) / 5 C... | 5 mg/1 | 5 | $2.13 | $1.931 | ● Active | CMS ASP |
| 16729-0050-53 | Temozolomide 100 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-050-53)... | 100 mg/1 | 100 | $42.50 | $4.761 | ● Active | CMS ASP |
| 16729-0050-54 | Temozolomide 100 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-050-54)... | 100 mg/1 | 280 | $119.00 | $4.761 | ● Active | CMS ASP |
| 47335-0892-72 | Temozolomide 100 mg/1 CAPSULE | Sun | 15 BLISTER PACK in 1 CARTON (47335-892-72)... | 100 mg/1 | 300 | $127.50 | $4.761 | ● Active | CMS ASP |
| 47335-0892-74 | Temozolomide 100 mg/1 CAPSULE | Sun | 5 BLISTER PACK in 1 CARTON (47335-892-74)... | 100 mg/1 | 100 | $42.50 | $4.761 | ● Active | CMS ASP |
| 65162-0803-14 | Temozolomide 100 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-803-14) / 14... | 100 mg/1 | 280 | $119.00 | $4.761 | ● Active | CMS ASP |
| 65162-0803-51 | Temozolomide 100 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-803-51) / 5 C... | 100 mg/1 | 100 | $42.50 | $4.761 | ● Active | CMS ASP |
| 16729-0129-53 | Temozolomide 140 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-129-53)... | 140 mg/1 | 140 | $59.50 | $11.461 | ● Active | CMS ASP |
| 16729-0129-54 | Temozolomide 140 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-129-54)... | 140 mg/1 | 392 | $166.60 | $11.461 | ● Active | CMS ASP |
| 47335-0929-72 | Temozolomide 140 mg/1 CAPSULE | Sun | 15 BLISTER PACK in 1 CARTON (47335-929-72)... | 140 mg/1 | 420 | $178.50 | $11.461 | ● Active | CMS ASP |
| 47335-0929-74 | Temozolomide 140 mg/1 CAPSULE | Sun | 5 BLISTER PACK in 1 CARTON (47335-929-74)... | 140 mg/1 | 140 | $59.50 | $11.461 | ● Active | CMS ASP |
| 65162-0804-14 | Temozolomide 140 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-804-14) / 14... | 140 mg/1 | 392 | $166.60 | $11.461 | ● Active | CMS ASP |
| 65162-0804-51 | Temozolomide 140 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-804-51) / 5 C... | 140 mg/1 | 140 | $59.50 | $11.461 | ● Active | CMS ASP |
| 16729-0051-53 | Temozolomide 250 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-051-53)... | 250 mg/1 | 250 | $106.25 | $20.533 | ● Active | CMS ASP |
| 47335-0893-74 | Temozolomide 250 mg/1 CAPSULE | Sun | 5 BLISTER PACK in 1 CARTON (47335-893-74)... | 250 mg/1 | 250 | $106.25 | $20.533 | ● Active | CMS ASP |
| 65162-0806-51 | Temozolomide 250 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-806-51) / 5 C... | 250 mg/1 | 250 | $106.25 | $20.533 | ● Active | CMS ASP |
| 16729-0130-53 | Temozolomide 180 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-130-53)... | 180 mg/1 | 180 | $76.50 | $21.413 | ● Active | CMS ASP |
| 16729-0130-54 | Temozolomide 180 mg/1 CAPSULE | Accord | 1 BOTTLE, GLASS in 1 CARTON (16729-130-54)... | 180 mg/1 | 504 | $214.20 | $21.413 | ● Active | CMS ASP |
| 47335-0930-72 | Temozolomide 180 mg/1 CAPSULE | Sun | 15 BLISTER PACK in 1 CARTON (47335-930-72)... | 180 mg/1 | 540 | $229.50 | $21.413 | ● Active | CMS ASP |
| 47335-0930-74 | Temozolomide 180 mg/1 CAPSULE | Sun | 5 BLISTER PACK in 1 CARTON (47335-930-74)... | 180 mg/1 | 180 | $76.50 | $21.413 | ● Active | CMS ASP |
| 65162-0805-14 | Temozolomide 180 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-805-14) / 14... | 180 mg/1 | 504 | $214.20 | $21.413 | ● Active | CMS ASP |
| 65162-0805-51 | Temozolomide 180 mg/1 CAPSULE | Amneal | 1 BOTTLE in 1 CARTON (65162-805-51) / 5 C... | 180 mg/1 | 180 | $76.50 | $21.413 | ● Active | CMS ASP |
| 50268-0761-12 | Temozolomide | AvPAK | — | — | 80 | $34.00 | — | — | CMS ASP |
| 50268-0762-12 | Temozolomide | AvPAK | — | — | 400 | $170.00 | — | — | CMS ASP |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$858.1K
Claims
5,402
Beneficiaries
2,249
Spend / beneficiary
$381.53
Spend / claim
$158.84
Trend by period
Where J8700 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #395 of 824
#390
REBYOTA J1440
$905.2K
#391
LAMZEDE J0217
$903.9K
#392
ELELYSO J3060
$871.5K
#393
VIVITROL J2315
$866.4K
#394
SPEVIGO J1747
$863.1K
#395
TEMOZOLOMIDE J8700
$858.1K
#396
INTEGRA BMWD** Q4104
$855.9K
#397
REZZAYO J0349
$844.7K
#398
NIVESTYM Q5110
$835.2K
#399
FEIBA J7198
$830K
#400
CYCLOSPORINE MODIFIE... J7515
$811.9K
Total claims — #215 of 824
#210
FUROSEMIDE(J1938) J1938
5,781
#211
HYDROCORTISONE SOD S... J1720
5,777
#212
DESCOVY J0751
5,521
#213
CYCLOPHOSPHAMIDE(J90... J9073
5,505
#214
KANJINTI Q5117
5,430
#215
TEMOZOLOMIDE J8700
5,402
#216
NAROPIN* J2795
5,366
#217
PHESGO J9316
5,254
#218
ATROPINE SULFATE(J04... J0461
5,212
#219
TECVAYLI J9380
5,187
#220
MULTIHANCE A9577
5,179
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $858.1K | 2,249 | 5,402 | $381.53 | $158.84 |
| 2025 (Q1-Q4) | $2.63M | 5,108 | 25,080 | $514.73 | $104.83 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$0.00
Medicare paid
$0.00
Submitted services
1,868
Denial rate
100.0%
Submitted charges
$48.6K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk
35 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J8700 billing FAQ
What is HCPCS code J8700?
J8700 is a HCPCS Level II J-code used to bill Temozolomide, oral, 5 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J8700?
One unit of J8700 represents 5 MG. Report the number of units equal to the dose administered divided by 5 MG.
How many units of J8700 should I bill?
Divide the dose administered by the code's unit size (5 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J8700?
The Medicare Part B payment limit is $0.425 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.417 per unit. Payment limits are revised quarterly.
Which NDCs bill under J8700?
35 NDCs currently map to J8700 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J8700 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.